Skip to main content
Top
Published in: Journal of Translational Medicine 1/2006

Open Access 01-06-2006 | Research

Monocyte/macrophage and T-cell infiltrates in peritoneum of patients with ovarian cancer or benign pelvic disease

Authors: Xipeng Wang, Michael Deavers, Rebecca Patenia, Roland L Bassett Jr, Peter Mueller, Qing Ma, Ena Wang, Ralph S Freedman

Published in: Journal of Translational Medicine | Issue 1/2006

Login to get access

Abstract

Background

We previously showed that tumor-free peritoneum of patients with epithelial ovarian cancer (EOC) exhibited enhanced expression of several inflammatory response genes compared to peritoneum of benign disease. Here, we examined peritoneal inflammatory cell patterns to determine their concordance with selected enhanced genes.

Methods

Expression patterns of selected inflammatory genes were mined from our previously published data base. Bilateral pelvic peritoneal and subjacent stromal specimens were obtained from 20 women with EOC and 7 women with benign pelvic conditions. Sections were first stained by indirect immunoperoxidase and numbers of monocytes/macrophages (MO/MA), T cells, B cells, and NK cells counted. Proportions of CD68+ cells and CD3+ cells that coexpressed MO/MA differentiation factors (CD163, CCR1, CXCR8, VCAM1, and phosphorylated cytosolic phospholipase A2 [pcPLA2]), which had demonstrated expression in EOC peritoneal samples, were determined by multicolor immunofluorescence.

Results

MO/MA were present on both sides of the pelvic peritoneum in EOC patients, with infiltration of the subjacent stroma and mesothelium. CD68+ MO/MA, the most commonly represented population, and CD3+ T cells were present more often in EOC than in benign pelvic tumors. NK cells, B cells, and granulocytes were rare. CXCL8 (IL-8) and the chemokine receptor CCR1 were coexpressed more frequently on MO/MA than on CD3+ cells contrasting with CD68+/CD163+ cells that coexpressed CXCL8 less often. An important activated enzyme in the eicosanoid pathway, pcPLA2, was highly expressed on both CD68+ and CD163+ cells. The adherence molecule Vascular Cell Adhesion Molecule-1 (VCAM1) was expressed on CD31+ endothelial cells and on a proportion of CD68+ MO/MA but rarely on CD3+ cells.

Conclusion

The pelvic peritoneum in EOC exhibits a general pattern of chronic inflammation, represented primarily by differentiated MO/MA, and distinct from that in benign conditions concordant with previous profiling results.
Appendix
Available only for authorised users
Literature
1.
go back to reference Rubin SC, Randall TC, Armstrong KA, Chi DS, Hoskins WJ: Ten-year follow-up of ovarian cancer patients after second-look laparotomy with negative findings. Obstet Gynecol. 1999, 93: 21-24. 10.1016/S0029-7844(98)00334-2.CrossRefPubMed Rubin SC, Randall TC, Armstrong KA, Chi DS, Hoskins WJ: Ten-year follow-up of ovarian cancer patients after second-look laparotomy with negative findings. Obstet Gynecol. 1999, 93: 21-24. 10.1016/S0029-7844(98)00334-2.CrossRefPubMed
2.
go back to reference Dedrick RL, Flessner MF: Pharmacokinetic problems in peritoneal drug administration: tissue penetration and surface exposure. J Natl Cancer Inst. 1997, 89: 480-487. 10.1093/jnci/89.7.480.CrossRefPubMed Dedrick RL, Flessner MF: Pharmacokinetic problems in peritoneal drug administration: tissue penetration and surface exposure. J Natl Cancer Inst. 1997, 89: 480-487. 10.1093/jnci/89.7.480.CrossRefPubMed
3.
go back to reference Carter D, True L, Otis C: Serous Membranes. Histology for Pathologists, 2nd Edition. Edited by: Sternberg S. 1997, Philadelphia, Lippincott-Raven, 223-239. Carter D, True L, Otis C: Serous Membranes. Histology for Pathologists, 2nd Edition. Edited by: Sternberg S. 1997, Philadelphia, Lippincott-Raven, 223-239.
4.
go back to reference Battifora H, McCaughey W: Tumors of the serosal membranes. Atlas of tumor pathology, Third series. Edited by: Pathology UARE. 1995, Bethesda, Armed Forces Institute of Pathology, 1: Battifora H, McCaughey W: Tumors of the serosal membranes. Atlas of tumor pathology, Third series. Edited by: Pathology UARE. 1995, Bethesda, Armed Forces Institute of Pathology, 1:
5.
go back to reference Freedman RS, Deavers M, Liu J, Wang E: Peritoneal inflammation - A microenvironment for Epithelial Ovarian Cancer (EOC). J Transl Med. 2004, 2: 23-10.1186/1479-5876-2-23.PubMedCentralCrossRefPubMed Freedman RS, Deavers M, Liu J, Wang E: Peritoneal inflammation - A microenvironment for Epithelial Ovarian Cancer (EOC). J Transl Med. 2004, 2: 23-10.1186/1479-5876-2-23.PubMedCentralCrossRefPubMed
6.
go back to reference Wang E, Marincola FM: Amplification of small quantities of mRNA for transcript analysis. DNA arrays—amolecular cloning manual 1st ed. Edited by: Bowtell D and J S. 2002, Cold Spring Harbor Laboratory, Cold Spring Harbor (NY), 204-213. Wang E, Marincola FM: Amplification of small quantities of mRNA for transcript analysis. DNA arrays—amolecular cloning manual 1st ed. Edited by: Bowtell D and J S. 2002, Cold Spring Harbor Laboratory, Cold Spring Harbor (NY), 204-213.
7.
go back to reference Wang E, Miller LD, Ohnmacht GA, Liu ET, Marincola FM: High-fidelity mRNA amplification for gene profiling. Nat Biotechnol. 2000, 18: 457-459. 10.1038/74546.CrossRefPubMed Wang E, Miller LD, Ohnmacht GA, Liu ET, Marincola FM: High-fidelity mRNA amplification for gene profiling. Nat Biotechnol. 2000, 18: 457-459. 10.1038/74546.CrossRefPubMed
8.
go back to reference Wang E: RNA amplification for successful gene profiling analysis. J Transl Med. 2005, 3: Wang E: RNA amplification for successful gene profiling analysis. J Transl Med. 2005, 3:
9.
go back to reference Wang E, Ngalame Y, Panelli MC, Nguyen-Jackson H, Deavers M, Mueller P, Hu W, Savary CA, Kobayashi R, Freedman RS, Marincola FM: Peritoneal and Subperitoneal Stroma May Facilitate Regional Spread of Ovarian Cancer. Clin Cancer Res. 2005, 11: 113-122.PubMed Wang E, Ngalame Y, Panelli MC, Nguyen-Jackson H, Deavers M, Mueller P, Hu W, Savary CA, Kobayashi R, Freedman RS, Marincola FM: Peritoneal and Subperitoneal Stroma May Facilitate Regional Spread of Ovarian Cancer. Clin Cancer Res. 2005, 11: 113-122.PubMed
10.
go back to reference Gordinier ME, Zhang HZ, Patenia R, Levy LB, Atkinson EN, Nash MA, Katz RL, Platsoucas CD, Freedman RS: Quantitative analysis of transforming growth factor-beta (TGF-beta 1 and TGF-beta2) on ovarian carcinoma. Clinical Cancer Research. 1999, 5: 2498-2505.PubMed Gordinier ME, Zhang HZ, Patenia R, Levy LB, Atkinson EN, Nash MA, Katz RL, Platsoucas CD, Freedman RS: Quantitative analysis of transforming growth factor-beta (TGF-beta 1 and TGF-beta2) on ovarian carcinoma. Clinical Cancer Research. 1999, 5: 2498-2505.PubMed
11.
go back to reference Freedman RS, Lenzi R, Kudelka AP, Rosenblum M, Platsoucas CD: Intraperitoneal immunotherapy of peritoneal carcinomatosis. Cytokines, Cellular and Molecular Therapy. 1998, 4: 121-140.PubMed Freedman RS, Lenzi R, Kudelka AP, Rosenblum M, Platsoucas CD: Intraperitoneal immunotherapy of peritoneal carcinomatosis. Cytokines, Cellular and Molecular Therapy. 1998, 4: 121-140.PubMed
12.
13.
go back to reference Ross DT, Scherf U, Eisen MB, Perou CM, Rees C, Spellman P, Iyer V, Jeffery SS, Van de Rijn M, Waltham M, Pergamenschikov A, Lee J, Lashkari D, Shalon D, Myers TG, Weinstein JN, Botstein D, Brown PO: Systematic variation in gene expression patterns in human cancer cell lines. Nature Genetics. 2000, 24: 227-235. 10.1038/73432.CrossRefPubMed Ross DT, Scherf U, Eisen MB, Perou CM, Rees C, Spellman P, Iyer V, Jeffery SS, Van de Rijn M, Waltham M, Pergamenschikov A, Lee J, Lashkari D, Shalon D, Myers TG, Weinstein JN, Botstein D, Brown PO: Systematic variation in gene expression patterns in human cancer cell lines. Nature Genetics. 2000, 24: 227-235. 10.1038/73432.CrossRefPubMed
14.
go back to reference O'Brien PC: Procedures for comparing samples wtih multiple endpoints. Biometrics. 1984, 40: 1079-10.2307/2531158.CrossRefPubMed O'Brien PC: Procedures for comparing samples wtih multiple endpoints. Biometrics. 1984, 40: 1079-10.2307/2531158.CrossRefPubMed
15.
go back to reference Chamorro S, Revilla C, Alvarez B, Alonso F, Esquerra A, Dominguez J: Phenotypic and functional heterogeneity of porcine blood monocytes and its relation with maturation. Immunology. 2005, 114: 63-71. 10.1111/j.1365-2567.2004.01994.x.PubMedCentralCrossRefPubMed Chamorro S, Revilla C, Alvarez B, Alonso F, Esquerra A, Dominguez J: Phenotypic and functional heterogeneity of porcine blood monocytes and its relation with maturation. Immunology. 2005, 114: 63-71. 10.1111/j.1365-2567.2004.01994.x.PubMedCentralCrossRefPubMed
16.
go back to reference Ordonez NG, Freedman RS, Herlyn M: Lewis and related tumor-associated determinants on ovarian carcinoma. Gynecol Oncol. 1987, 26: 1-10. 10.1016/0090-8258(87)90065-5.CrossRefPubMed Ordonez NG, Freedman RS, Herlyn M: Lewis and related tumor-associated determinants on ovarian carcinoma. Gynecol Oncol. 1987, 26: 1-10. 10.1016/0090-8258(87)90065-5.CrossRefPubMed
17.
go back to reference Loercher AE, Nash MA, Kavanagh JJ, Platsoucas CD, Freedman RS: Identification of an IL-10-producing HLA-DR-negative monocyte subset in the malignant ascites of patients with ovarian carcinoma that inhibits cytokine protein expression and proliferation of autologous T cells. J Immunol. 1999, 163: 6251-6260.PubMed Loercher AE, Nash MA, Kavanagh JJ, Platsoucas CD, Freedman RS: Identification of an IL-10-producing HLA-DR-negative monocyte subset in the malignant ascites of patients with ovarian carcinoma that inhibits cytokine protein expression and proliferation of autologous T cells. J Immunol. 1999, 163: 6251-6260.PubMed
18.
go back to reference Gordon IO, Freedman RS: Defective antitumor function of monocyte-derived macrophages from epithelial ovarian cancer patients. Clin Cancer Res. 2006, In press: Gordon IO, Freedman RS: Defective antitumor function of monocyte-derived macrophages from epithelial ovarian cancer patients. Clin Cancer Res. 2006, In press:
19.
go back to reference Mantovani A, Sozzani S, Locati M, Allavena P, Sica A: Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 2002, 23: 549-555. 10.1016/S1471-4906(02)02302-5.CrossRefPubMed Mantovani A, Sozzani S, Locati M, Allavena P, Sica A: Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 2002, 23: 549-555. 10.1016/S1471-4906(02)02302-5.CrossRefPubMed
20.
go back to reference Orre M, Rogers PA: Macrophages and microvessel density in tumors of the ovary. Gynecol Oncol. 1999, 73: 47-50. 10.1006/gyno.1998.5292.CrossRefPubMed Orre M, Rogers PA: Macrophages and microvessel density in tumors of the ovary. Gynecol Oncol. 1999, 73: 47-50. 10.1006/gyno.1998.5292.CrossRefPubMed
21.
go back to reference Negus RP, Stamp GW, Relf MG, Burke F, Malik ST, Bernasconi S, Allavena P, Sozzani S, Mantovani A, Balkwill FR: The detection and localization of monocyte chemoattractant protein-1 (MCP-1) in human ovarian cancer. J Clin Invest. 1995, 95: 2391-2396.PubMedCentralCrossRefPubMed Negus RP, Stamp GW, Relf MG, Burke F, Malik ST, Bernasconi S, Allavena P, Sozzani S, Mantovani A, Balkwill FR: The detection and localization of monocyte chemoattractant protein-1 (MCP-1) in human ovarian cancer. J Clin Invest. 1995, 95: 2391-2396.PubMedCentralCrossRefPubMed
22.
go back to reference Schutyser E, Struyf S, Proost P, Opdenakker G, Laureys G, Verhasselt B, Peperstraete L, Van de Putte I, Saccani A, Allavena P, Mantovani A, Van Damme J: Identification of biologically active chemokine isoforms from ascitic fluid and elevated levels of CCL18/pulmonary and activation-regulated chemokine in ovarian carcinoma. J Biol Chem. 2002, 277: 24584-24593. 10.1074/jbc.M112275200.CrossRefPubMed Schutyser E, Struyf S, Proost P, Opdenakker G, Laureys G, Verhasselt B, Peperstraete L, Van de Putte I, Saccani A, Allavena P, Mantovani A, Van Damme J: Identification of biologically active chemokine isoforms from ascitic fluid and elevated levels of CCL18/pulmonary and activation-regulated chemokine in ovarian carcinoma. J Biol Chem. 2002, 277: 24584-24593. 10.1074/jbc.M112275200.CrossRefPubMed
23.
go back to reference Philippidis P, Mason JC, Evans BJ, Nadra I, Taylor KM, Haskard DO, Landis RC: Hemoglobin scavenger recepter CD163 mediates interleukin-10 release and heme oxygenase-1 synthesis: antiinflammatory monocyte-macrophage responses in vitro, in resolving skin blisters in vivo, and after cardiopulmonary bypass surgery. Circulation Research. 2004, 94: 119-126. 10.1161/01.RES.0000109414.78907.F9.CrossRefPubMed Philippidis P, Mason JC, Evans BJ, Nadra I, Taylor KM, Haskard DO, Landis RC: Hemoglobin scavenger recepter CD163 mediates interleukin-10 release and heme oxygenase-1 synthesis: antiinflammatory monocyte-macrophage responses in vitro, in resolving skin blisters in vivo, and after cardiopulmonary bypass surgery. Circulation Research. 2004, 94: 119-126. 10.1161/01.RES.0000109414.78907.F9.CrossRefPubMed
24.
go back to reference Ivarsson K, Ekerydh A, Fyhr IM, Janson PO, Brannstrom M: Upregulation of interleukin-8 and polarized epithelial expression of interleukin-8 receptor A in ovarian carcinomas. Acta Obstet Gynecol Scand. 2000, 79: 777-784. 10.1034/j.1600-0412.2000.079009777.x.PubMed Ivarsson K, Ekerydh A, Fyhr IM, Janson PO, Brannstrom M: Upregulation of interleukin-8 and polarized epithelial expression of interleukin-8 receptor A in ovarian carcinomas. Acta Obstet Gynecol Scand. 2000, 79: 777-784. 10.1034/j.1600-0412.2000.079009777.x.PubMed
25.
go back to reference Gawrychowski K, Skopinska-Rozewska E, Barcz E, Sommer E, Szaniawska B, Roszkowska-Purska K, Janik P, Zielinski J: Angiogenic activity and interleukin-8 content of human ovarian cancer ascites. Eur J Gynaecol Oncol. 1998, 19: 262-264.PubMed Gawrychowski K, Skopinska-Rozewska E, Barcz E, Sommer E, Szaniawska B, Roszkowska-Purska K, Janik P, Zielinski J: Angiogenic activity and interleukin-8 content of human ovarian cancer ascites. Eur J Gynaecol Oncol. 1998, 19: 262-264.PubMed
26.
go back to reference Kassim SK, El-Salahy EM, Fayed ST, Helal SA, Helal T, Azzam Eel D, Khalifa A: Vascular endothelial growth factor and interleukin-8 are associated with poor prognosis in epithelial ovarian cancer patients. Clin Biochem. 2004, 37: 363-369. 10.1016/j.clinbiochem.2004.01.014.CrossRefPubMed Kassim SK, El-Salahy EM, Fayed ST, Helal SA, Helal T, Azzam Eel D, Khalifa A: Vascular endothelial growth factor and interleukin-8 are associated with poor prognosis in epithelial ovarian cancer patients. Clin Biochem. 2004, 37: 363-369. 10.1016/j.clinbiochem.2004.01.014.CrossRefPubMed
27.
go back to reference Wiley SR, Schooley K, Smolak PJ, Din WS, Huang CP, Nicholl JK, Sutherland GR, Smith TD, Rauch C, Smith CA: Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity. 1995, 3: 673-682. 10.1016/1074-7613(95)90057-8.CrossRefPubMed Wiley SR, Schooley K, Smolak PJ, Din WS, Huang CP, Nicholl JK, Sutherland GR, Smith TD, Rauch C, Smith CA: Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity. 1995, 3: 673-682. 10.1016/1074-7613(95)90057-8.CrossRefPubMed
28.
go back to reference Abdollahi T, Robertson NM, Abdollahi A, Litwack G: Identification of interleukin 8 as an inhibitor of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in the ovarian carcinoma cell line OVCAR3. Cancer Res. 2003, 63: 4521-4526.PubMed Abdollahi T, Robertson NM, Abdollahi A, Litwack G: Identification of interleukin 8 as an inhibitor of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in the ovarian carcinoma cell line OVCAR3. Cancer Res. 2003, 63: 4521-4526.PubMed
29.
go back to reference So J, Navari J, Wang FQ, Fishman DA: Lysophosphatidic acid enhances epithelial ovarian carcinoma invasion through the increased expression of interleukin-8. Gynecol Oncol. 2004, 95: 314-322. 10.1016/j.ygyno.2004.08.001.CrossRefPubMed So J, Navari J, Wang FQ, Fishman DA: Lysophosphatidic acid enhances epithelial ovarian carcinoma invasion through the increased expression of interleukin-8. Gynecol Oncol. 2004, 95: 314-322. 10.1016/j.ygyno.2004.08.001.CrossRefPubMed
30.
go back to reference Boonstra J, Verkleij AJ: Regulation of enzyme activity in vivo is determined by its cellular localization. Advances in Enzyme Regulation. 2004, 44: 61-73.CrossRefPubMed Boonstra J, Verkleij AJ: Regulation of enzyme activity in vivo is determined by its cellular localization. Advances in Enzyme Regulation. 2004, 44: 61-73.CrossRefPubMed
31.
go back to reference Grewal S, Morrison EE, Ponnambalam S, Walker JH: Nuclear localization of cytosolic phospholipase A2-alpha in the EA.hy.926 human endothelial cell line is proliferation dependent and modulated by phosphorylation. J of Cell Science. 2002, 115: Grewal S, Morrison EE, Ponnambalam S, Walker JH: Nuclear localization of cytosolic phospholipase A2-alpha in the EA.hy.926 human endothelial cell line is proliferation dependent and modulated by phosphorylation. J of Cell Science. 2002, 115:
32.
go back to reference Xu Y, Shen Z, Wiper DW, Wu M, Morton RE, Elson P, Kennedy AW, Belinson J, Markman M, Casey G: Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers. Jama. 1998, 280: 719-723. 10.1001/jama.280.8.719.CrossRefPubMed Xu Y, Shen Z, Wiper DW, Wu M, Morton RE, Elson P, Kennedy AW, Belinson J, Markman M, Casey G: Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers. Jama. 1998, 280: 719-723. 10.1001/jama.280.8.719.CrossRefPubMed
33.
go back to reference Freedman RS, Edwards CL, Kavanagh JJ, Kudelka AP, Katz RL, Carrasco CH, Atkinson EH, Scott W, Tomasovic B, Platsoucas CD: Intraperitoneal adoptive immunotherapy of ovarian carcinoma with tumor infiltrating lymphocytes, A pilot trial. J Immunother. 1994, 16: 198-210.CrossRef Freedman RS, Edwards CL, Kavanagh JJ, Kudelka AP, Katz RL, Carrasco CH, Atkinson EH, Scott W, Tomasovic B, Platsoucas CD: Intraperitoneal adoptive immunotherapy of ovarian carcinoma with tumor infiltrating lymphocytes, A pilot trial. J Immunother. 1994, 16: 198-210.CrossRef
34.
go back to reference Nash MA, Lenzi R, Edwards CL, Kavanagh JJ, Kudelka AP, Verschraegen CF, Platsoucas CD, Freedman RS: Differential expression of cytokine transcripts in human epithelial ovarian carcinoma by solid tumor specimens, peritoneal exudate cells containing tumor, TIL-derived T-cell lines and established tumor cell lines. Clin Exp Immunol. 1998, 112: 172-180. 10.1046/j.1365-2249.1998.00576.x.PubMedCentralCrossRefPubMed Nash MA, Lenzi R, Edwards CL, Kavanagh JJ, Kudelka AP, Verschraegen CF, Platsoucas CD, Freedman RS: Differential expression of cytokine transcripts in human epithelial ovarian carcinoma by solid tumor specimens, peritoneal exudate cells containing tumor, TIL-derived T-cell lines and established tumor cell lines. Clin Exp Immunol. 1998, 112: 172-180. 10.1046/j.1365-2249.1998.00576.x.PubMedCentralCrossRefPubMed
35.
go back to reference Moradi MM, Carson LF, Weinberg JB, Haney AF, Twiggs LB, Ramakrishnan S: Serum and ascitic fluid levels of interleukin-1, interleukin-6, and tumor necrosis factor-alpha in patients with ovarian epithelial cancer. Cancer. 1993, 72: 2433-2440. 10.1002/1097-0142(19931015)72:8<2433::AID-CNCR2820720822>3.0.CO;2-L.CrossRefPubMed Moradi MM, Carson LF, Weinberg JB, Haney AF, Twiggs LB, Ramakrishnan S: Serum and ascitic fluid levels of interleukin-1, interleukin-6, and tumor necrosis factor-alpha in patients with ovarian epithelial cancer. Cancer. 1993, 72: 2433-2440. 10.1002/1097-0142(19931015)72:8<2433::AID-CNCR2820720822>3.0.CO;2-L.CrossRefPubMed
36.
go back to reference Burke F, Relf M, Negus RP, Balkwill FR: A cytokine profile of normal and malignant ovary. Cytokine. 1996, 8: 578-585. 10.1006/cyto.1996.0077.CrossRefPubMed Burke F, Relf M, Negus RP, Balkwill FR: A cytokine profile of normal and malignant ovary. Cytokine. 1996, 8: 578-585. 10.1006/cyto.1996.0077.CrossRefPubMed
37.
go back to reference Berek JS, Chung C, Kaldi K, Watson JM, Knox RM, Martinez-Maza O: Serum interleukin-6 levels correlate with disease status in patients with epithelial ovarian cancer. Am J Obstet Gynecol. 1991, 164: 1038-1042.CrossRefPubMed Berek JS, Chung C, Kaldi K, Watson JM, Knox RM, Martinez-Maza O: Serum interleukin-6 levels correlate with disease status in patients with epithelial ovarian cancer. Am J Obstet Gynecol. 1991, 164: 1038-1042.CrossRefPubMed
38.
go back to reference Nash MA, Ferrandina G, Gordinier ME, Loercher AE, Freedman RS: The role of cytokines in both the normal and malignant ovary. Endocrine-Related Cancer. 1999, 6: 93-107. 10.1677/erc.0.0060093.CrossRefPubMed Nash MA, Ferrandina G, Gordinier ME, Loercher AE, Freedman RS: The role of cytokines in both the normal and malignant ovary. Endocrine-Related Cancer. 1999, 6: 93-107. 10.1677/erc.0.0060093.CrossRefPubMed
Metadata
Title
Monocyte/macrophage and T-cell infiltrates in peritoneum of patients with ovarian cancer or benign pelvic disease
Authors
Xipeng Wang
Michael Deavers
Rebecca Patenia
Roland L Bassett Jr
Peter Mueller
Qing Ma
Ena Wang
Ralph S Freedman
Publication date
01-06-2006
Publisher
BioMed Central
Published in
Journal of Translational Medicine / Issue 1/2006
Electronic ISSN: 1479-5876
DOI
https://doi.org/10.1186/1479-5876-4-30

Other articles of this Issue 1/2006

Journal of Translational Medicine 1/2006 Go to the issue